Pharma ad police issues 2019's first warning over promotion of unapproved imaging drug

The first FDA drug marketing warning letter of the year goes to ... a drug that’s not yet approved. OPDP issued an untitled letter to Phoenix Molecular Imaging Center for its investigational Sodium Acetate C-11.